MUSCAT / WAM The latest data released by the Statistical Centre for the Cooperation Council ...
Read More »Alzheimer’s furor shows US health system’s flaws
Patients and their families may see hope in the news that the Food and Drug Administration (FDA) has approved a drug to slow the pace of Alzheimer’s disease. Aducanumab is the first medicine authorised to treat what might be an underlying cause of the disease: amyloid beta clumps that accumulate in the brain. Yet the evidence from clinical trials that ...
Read More »